August 25, 2021 WEBINAR | Alternative Solutions in Safety Assessment When: August 25, 2021, 10 – 11:30 a.m. ET C-Path’s Predictive Safety Testing Consortium (PSTC) invites you to this free webi
August 17, 2021 View Now | C-Path Neuroscience Program Webinar – NfL in Neurodegenerative Diseases C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members,
July 21, 2021 View Now | How RDCA-DAP Can Help Inform Optimal Trial Design in Progressive Rare Disease When: July 21, 2021, 12 p.m. ET Case Study: Northstar Ambulatory Assessment as an outcome assessment in Duchenne muscular
July 16, 2021 View Now | RDCA-DAP Webinar Series: Value of Integrated Data and Analytics in Rare Disease Drug Development When: June 16, 2021, 12 p.m. ET Case Study: Modeling disease progression in polycystic kidney disease to inform tr
July 15, 2021-July 26, 2021 VIEW NOW | Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Considerations for Drug Development Critical Path Institute held a free virtual workshop, Design of Clinical Trials in New-Onset Type 1 Diabetes: Regulatory Cons
May 19, 2021-May 20, 2021 View Now | 2021 PKD Regulatory Summit | May 19-20 The Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium (PKDOC), The PKD Foundation and Otsuka invite you vi
May 19, 2021 View Now | Interpretation of novel biomarkers in related diseases through data interoperability in a pan-rare disease database When: May 19, 2021, 12 p.m. ET Example Disease: Polycystic kidney disease and kidney transplant Presenters: Jagde
May 7, 2021 Pediatric COVID-19 Mitigation Strategies Virtual Workshop Click here for WebEx link On May 7th, 2021, 12:00-1:30 PM Eastern Time (US), the PRO Consortium and Rare Disease Su
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop Friday May 7, 2021 12:00 – 1:30 pm Ea
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w
